Educational information only. Not medical advice. SafePeptideUse sells nothing and is not a substitute for a qualified clinician. Talk to a healthcare professional before making any health decision.
SafePeptideUse logoSafePeptideUse

Melanotan II

Also known as MT-II, MT2, Melanotan 2

Not approved in the USSkin & anti-agingSexual health

Last reviewed · Awaiting clinical review

Main safety concerns

Not FDA approved. It darkens and can change moles, which makes spotting skin cancer harder. Avoid it if you have many or atypical moles or any history of melanoma, and have a dermatologist check your skin.

Educational information, not medical advice. If you have symptoms that worry you, contact a clinician or emergency services.

What is known

A melanocortin agonist injected to darken skin and, at higher doses, to raise libido. Not approved, and it carries real skin risks.

Status:
FDA considers it an unapproved new drug. FDA has flagged safety concerns, and case reports link it to melanoma and other serious harms.[3] [4]
Strongest evidence for any claim:

See the evidence claim by claim

What it is and how it works

Melanotan II is a synthetic copy of alpha-MSH that switches on melanocortin receptors. Through the MC1 receptor it makes skin produce more melanin, which darkens it with less sun. Through MC3 and MC4 receptors in the brain it can raise sexual desire and cause erections. That same broad receptor activity is why it commonly causes nausea, flushing, and appetite loss.[1]

Evidence by claim

Each claim is graded on its own. Tap a grade to see what it does and does not mean.

  • Darkens skin with less sun exposure.

    Source type: Review

    It clearly works, mostly documented through user reports and small studies. It is not a safe or approved tanning method.

  • Raises libido and causes erections.

    Reported by users. Its relative PT-141 is the studied and approved option for sexual desire.

    No source cited for this claim.

Reported side effects

  • SeriousRaised blood pressure and rare serious events(rare)[1]Reports include atypical moles (dysplastic nevi) and rare events such as kidney infarction. Long term safety has not been studied.
  • WarningNew or changing moles and freckles(common)[1]It darkens existing moles and can create new ones. Any changing mole needs a dermatologist, because this can hide or mimic skin cancer.
  • CautionNausea(common)[1]Common right after a dose, and worse at higher doses.
  • CautionFacial flushing(common)[1]
  • InfoDecreased appetite(common)[1]
  • InfoSpontaneous erections(common)[1]More likely at the higher libido doses.

Interactions and combination risks

  • CautionPT-141 or other melanocortin agonists

    They share a mechanism, so combining adds to the nausea and blood pressure effects.

Who should avoid it

  • SeriousMany or atypical moles, or a personal or family history of melanoma

    It changes moles and could hide or drive skin cancer. This is the most important reason to avoid it.

  • SeriousUncontrolled high blood pressure or heart disease

    It can raise blood pressure.

  • SeriousPregnancy or breastfeeding

    No safety data in pregnancy or breastfeeding.

Dosing

Placed after the evidence and risks on purpose. Nothing here is a recommendation for you.

Community reported use, not tested in trials
Route(s)subcutaneous
Typical rangeFor tanning, often about 200 mcg daily for a week, then 100 mcg twice weekly once color builds. For libido, higher doses around 0.5 to 2 mg are used, which bring more side effects.
FrequencyDaily during loading, then a couple of times a week
Cycle guidanceCycled, for example 4 to 8 weeks on with breaks. A lower total dose means fewer side effects.
NotesNot approved, and the dosing is entirely community derived. Start very low, since nausea and flushing are common. This does not protect against sunburn or skin cancer. A darker tan is not a safe substitute for sun protection.
[1]

For the equipment itself, see syringes, needles, and the rest of the kit.

Reconstitution

Vial sizes10 mg
DiluentBacteriostatic water for multi dose vials, or sterile water for single use
ConcentrationTanning doses are tiny, so mix dilute for an easy draw. Example: a 10 mg vial plus 5 mL of water gives 2 mg/mL, so a 200 mcg dose is 0.1 mL, which is 10 units on a U-100 syringe.
NotesMelanotan II usually ships as 10 mg freeze dried vials. Because tanning doses are small, a more dilute mix is easier to measure accurately.

General reconstitution technique

Units and volume arithmetic

Converts between an amount and syringe units for the vial and diluent you enter. It starts empty and does not suggest an amount. Open the full calculator

Inputs

What do you want to convert?
  1. mg

    Total amount printed on the vial label.

    Sizes sold:
  2. mL

    Volume of bacteriostatic water already in the vial.

  3. Check the unit. 1 mg = 1,000 mcg, so the wrong one is a 1,000x error.

  4. U-100

    Printed on the syringe wrapper. Results over this size are shown as invalid.

Result

Fill in steps 1 to 3 to see the arithmetic. Nothing here is a suggested amount.

Settings live in the address bar, so a pasted link reopens this calculator as you left it.

Educational arithmetic only. It does not choose an amount for you and is not medical or dosing advice. Verify every calculation independently.

Storage and stability

Dry powder (lyophilized)

TemperatureFreeze for long term storage, or 2 to 8 short term
Shelf lifeMany months when frozen
NotesKeep dry and out of light until you mix it.

After mixing

Temperature2 to 8 (refrigerated)
Shelf lifeAbout 2 to 4 weeks
NotesDo not freeze after mixing. Discard if cloudy or discolored.

General storage and stability guide

COA and purity notes

Common adulterantsunderdosed or mislabeled vials, material sold without clear content
MislabelingIt is unregulated, so a recent third party COA helps confirm what is in the vial.
NotesSold as an unapproved research and tanning chemical.

How to read a COA

Sources

  1. [1]User experiences of Melanotan II injection for tanning

    British Journal of Dermatology 2024 (opens source in a new tab)· Review
  2. [2]Advice on the use of injecting tanning agents such as Melanotan

    Drugs.ie (harm reduction guidance) 2024 (opens source in a new tab)· Other
  3. [3]Notice of Opportunity for Hearing: Edward Manookian (proposed debarment over sales of Melanotan II)

    U.S. Food & Drug Administration 2016 (opens source in a new tab)· Regulatory record
  4. [4]Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

    U.S. Food & Drug Administration 2026 (opens source in a new tab)· Regulatory record

Last reviewed 8 July 2026 · editorial status: reviewed